DNMT3A and acute myeloid leukemia: The most common DNMT3A mutation in human AML is a heterozygous R882H missense substitution (R878H in mice); this dominant negative mutation leads to an approximately 80% reduction in DNMT3A activity, causing focal, canonical DNA hypomethylation at thousands of regions across the genome (9, 12–14).